US Physical Therapy (USPH) Misses Q3 EPS by 1c; offers guidance

US Physical Therapy (NYSE: USPH) reported Q3 EPS of $0.66, $0.01 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $197.13 million versus the consensus estimate of $194.05 million.

2025 EARNINGS GUIDANCE

Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million, reflecting third-quarter results and the Company’s current expectations for the remainder of the year.

For earnings history and earnings-related data on US Physical Therapy (USPH) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• NV Gold closes final tranche of private placement, raising $1.4M
• Goldcana closes C$2M private placement, issues 8M units